After Exposure, Then What? Closing the COVID-19 Prevention Gap - European Medical Journal

This site is intended for healthcare professionals

After Exposure, Then What? Closing the COVID-19 Prevention Gap

This content was funded by an unrestricted educational grant from Shionogi Inc. (U.S.).

Even in 2026, SARS-CoV-2 transmission remains a real-world challenge in primary care, especially within households and high-contact settings. This webinar focuses on the prevention gap after exposure, where current post-exposure approaches can fall short, and why testing and timing are make-or-break constraints. 

Uncover

  • How exposure risk and urgency can differ across group homes, assisted living, care homes, and other congregate living 
  • Why clinical applicability is broad, including older adults, immunocompromised people, and those with underlying respiratory illnesses 
  • The importance of indirect populations including household members and healthcare workers who may transmit infection to vulnerable individuals 
  • Practical takeaways on testing to help avoid losing time after exposure 
  • How the PEP evidence landscape is evolving 

Speakers:

Stefan Gravenstein1

Lynn McNicoll2

1. Division of Geriatrics and Palliative Medicine, Brown University, Providence, Rhode Island, USA
2. Division of Geriatrics, Brown University,Providence, Rhode Island, USA 

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.